In Vitro Characterization & Assay Development Platform
Overview Solution Application What We Can Offer? Workflow Our Advantages Published Data FAQs
Facing protracted drug development cycles and challenges in validating new therapeutic candidates? Creative Biolabs' In Vitro Characterization and Assay Development services provide a strategic solution. Our advanced platforms and expert guidance help you streamline the drug discovery process, obtain high-quality data on your therapeutic agents, and accelerate your path from concept to clinical success. We leverage cutting-edge techniques and extensive experience to ensure your project's success through precise and reliable preclinical data.
In Vitro Characterization and Assay
In vitro characterization and assay development are fundamental pillars of modern drug discovery. They involve the use of laboratory techniques and cell-based models to understand a drug candidate's behavior before it enters living organisms. This process is essential for evaluating a wide range of properties, from a drug's fundamental mechanism of action and dose-response relationship (pharmacodynamics) to the performance of its delivery system. Recent literature underscores the importance of this field in the development of advanced therapies, such as mRNA vaccines delivered by lipid nanoparticles (LNPs), which require specialized assays to measure potency and efficacy. Similarly, the use of pH-responsive hydrogels and other nanocarriers for targeted delivery and controlled release necessitates rigorous in vitro testing to ensure their functionality and safety. By providing a controlled environment for testing, these methods allow researchers to efficiently screen drug candidates, optimize formulations, and predict potential toxicities, accelerating the transition from laboratory research to clinical trials.
Advantages of In Vitro Characterization for Targeted Delivery
-
Faster and More Cost-Effective Screening: In vitro assays allow for high-throughput screening of numerous drug candidates and delivery systems in a fraction of the time and cost required for in vivo studies. This accelerates the process of identifying the most promising candidates.
-
Enhanced Precision and Control: In vitro platforms provide a highly controlled environment, allowing for precise measurement of drug-target interactions, binding affinity, cellular uptake mechanisms, and drug release kinetics without the complexities of a whole organism.
-
Reduced Off-Target Effects: These assays are crucial for evaluating the specificity and selectivity of a targeted delivery system, helping to identify and minimize potential off-target binding or toxicity early in the development pipeline.
Our In vitro Solution
Creative Biolabs offers comprehensive, end-to-end solutions to accelerate your drug discovery programs, acting as a true scientific partner. We leverage our expertise and state-of-the-art platforms to proactively address the challenges of modern drug development, from initial screening to preclinical validation. Our goal is to streamline your workflow and provide the high-quality data needed to confidently advance your therapeutic assets. Our services include:
Fig.1 Targeted Delivery Inside the Cells Directly Visualized.1,3
-
Advanced In Vitro Platforms: We use state-of-the-art platforms to precisely measure drug performance, developing robust cell-based assays for drug-target interactions, potency, cellular uptake, and release kinetics. This provides the foundational data needed for understanding a drug's mechanism of action.
-
Drug Delivery System Analysis: Our analysis improves a drug's physicochemical properties like stability and solubility, which are crucial for enhancing bioavailability and targeted delivery. We use advanced characterization techniques like Dynamic Light Scattering (DLS) to measure particle size, Zeta Potential to analyze surface charge, Transmission Electron Microscopy (TEM) for detailed morphology, and Fourier-transform Infrared Spectroscopy (FTIR) to confirm chemical composition. This allows us to optimize drug encapsulation and design systems for selective delivery, such as liposomal drugs for the EPR effect.
-
Extensive In Vivo Platforms: We offer a diverse portfolio of in vivo platforms, including a variety of animal and cell models, and multiple administration routes like intravenous, subcutaneous, and oral. This allows us to select the most relevant system for your therapeutic area, simulate clinical conditions, and gather comprehensive data. These platforms are essential for validating our in vitro findings and bridging the gap to clinical stages.
-
Targeted Delivery Confirmation: Our platforms confirm targeted delivery and assess biodistribution using techniques like fluorescence or radioisotope imaging. This allows us to precisely track drug accumulation over time, providing crucial evidence that the therapeutic agent reaches its intended target while minimizing off-target effects.
Application
Targeted drug delivery is a revolutionary approach in medicine that aims to deliver therapeutic agents specifically to diseased cells or tissues while sparing healthy ones. Our in vitro characterization and assay development services are critical for this field, providing the tools to:
-
Vaccine Development: Our services are essential for next-generation vaccines, such as mRNA-LNP platforms. We help validate a vaccine's potency by measuring the efficiency of antigen expression and the stability of the LNP delivery system, ensuring a robust and predictable immune response.
-
Oncology: We help optimize nanocarriers for selective delivery of chemotherapy to solid tumors. By focusing the drug's activity, we can help minimize systemic toxicity and improve the therapeutic index, leading to safer and more effective cancer treatments.
-
Topical Treatments: For innovative creams and gels, we develop and test drug delivery systems like chitosan-decorated formulations. This ensures enhanced antibacterial activity for wound healing by improving drug penetration and providing sustained release at the site of infection.
-
Regenerative Medicine: We characterize antibiotic-loaded nanocarriers for dental applications to combat periodontitis and promote bone regeneration. Our methods help ensure that the nanocarrier not only delivers the therapeutic agent but also provides a scaffold that is compatible with local tissue to facilitate the regeneration process.
Contact Us About Bioconjugation Services
What We Can Offer?
At Creative Biolabs, we provide a robust portfolio of products and services to support your drug development journey, including:
Custom Assay Development
We design and validate specialized cell-based assays to accurately measure the potency, efficacy, and stability of your therapeutic agents, including mRNA-LNP vaccines.
Advanced Drug Delivery Systems
We offer expertise in characterizing and optimizing a wide range of drug delivery platforms. Our services focus on improving a drug's physicochemical properties, enhancing bioavailability, and achieving targeted delivery. This includes analysis of nanoparticles, liposomes, and pH-responsive hydrogels to ensure controlled drug release and improved pharmacokinetics.
Diverse In Vitro and In Vivo Platforms
Our state-of-the-art facilities include a variety of animal models (rodents, non-human primates) and a broad range of cell lines. We utilize multiple routes of administration to simulate real-world conditions, providing comprehensive data on drug performance and validation of targeted delivery.
Preclinical Validation
We conduct rigorous in vitro and in vivo testing to assess targeting efficiency, cellular uptake, and therapeutic efficacy, providing the critical data needed for successful IND applications.
Comprehensive Scientific Support
Our team of expert biologists and chemists provides end-to-end support, from initial experimental design to detailed data analysis, ensuring your project meets the highest scientific standards.
Workflow
Why Choose Us?
Choosing Creative Biolabs means partnering with a team that has a proven track record of success in drug discovery and development. Our commitment to innovation and scientific excellence ensures that your therapeutic agents are advanced with precision and confidence.
Proven Expertise
Our highly specialized team possesses deep scientific knowledge in drug delivery systems and cutting-edge assay development.
Innovative Technology
We leverage state-of-the-art platforms for nanoparticle characterization, custom assay development, and preclinical validation.
Tailored Customization & Flexibility
We provide bespoke services tailored to your specific therapeutic goals and project requirements, from concept to validation.
Rigorous Quality & Reliability
Our dedication to scientific rigor guarantees reliable, reproducible, and high-quality results for your critical projects.
Contact Our Experts Today
Published Data
Fig.2 (A) TEM image, (B) nitrogen sorption isotherm, and (C) pore size distribution calculated via non-local functional theory (NLDFT) of the calcinated MSNs.2,3
In a key study, researchers validated the targetability of peptide-functionalized mesoporous silica nanoparticles (MSNs) under biologically relevant conditions. The experiment focused on addressing the challenge of nanoparticles specifically engaging their target receptors when a "protein corona" forms on their surface in the presence of serum proteins. The study used MSNs functionalized with a high-affinity peptide ligand for somatostatin receptors. To accurately measure receptor engagement, a bioassay was developed using HEK293 cells that co-expressed a luminescent cAMP probe and the target receptor. The assay quantitatively measured the drop in intracellular cAMP levels, a direct indicator of receptor activation. The results demonstrated that the targeted nanoparticles, unlike their non-targeted counterparts, successfully engaged their receptors on living cells even with serum proteins present. This work highlights the critical importance of evaluating the stability and targeting capabilities of such nanoparticles under complex physiological conditions, providing a crucial framework for validating the effectiveness of targeted drug delivery systems.
FAQs
Q: Why is in vitro characterization so important for my project?
A: In vitro characterization provides a controlled, cost-effective way to get reliable data on your drug candidate's fundamental properties. It allows you to efficiently screen multiple formulations, identify the most promising candidates, and reduce the risk of failure in later, more expensive stages of development, like animal studies.
Q: How do you ensure the assays you develop are reliable and relevant to in vivo conditions?
A: Our assays are designed with an emphasis on biological relevance. We carefully select and optimize cell lines and conditions to mimic the target disease environment as closely as possible. Furthermore, we validate our in vitro findings with parallel in vivo studies to ensure a strong correlation and provide a reliable bridge to clinical translation.
Q: Can your services help me with my specific drug delivery system, like a novel nanoparticle?
A: Absolutely. Our expertise lies in a wide range of drug delivery systems, including liposomes, polymeric nanoparticles, and LNPs. We can work with your specific system to develop custom assays that characterize its stability, drug loading efficiency, and targeted delivery capabilities, tailoring our approach to your unique needs.
Q: My drug has poor solubility. Can in vitro characterization help me solve this?
A: Yes. In vitro characterization is crucial for optimizing formulations to overcome challenges like poor solubility. We can test different delivery systems and excipients to improve the drug's physicochemical properties, enhancing its solubility and ensuring its successful delivery to the target site.
Q: How do you measure nanoparticle toxicity?
A: We assess nanoparticle toxicity using a variety of in vitro methods that are designed for rapid screening. These methods evaluate the effects of nanoparticles on cellular health, including oxidative stress, inflammation, and cell viability, which helps us to identify minimum toxic doses and predict potential health impacts before moving to more extensive in vivo testing.
At Creative Biolabs, we are committed to providing the highest quality in vitro characterization and assay development services to advance your research. Our expert team is ready to discuss your specific needs and help you accelerate your path to discovery.
Connect with our experts for project-specific consultation and detailed insights.
References
-
Zlotnikov, Igor D et al. "Targeted Delivery Inside the Cells Directly Visualized with Förster Resonance Energy Transfer (FRET)." Polymers vol. 17,6 790. 16 Mar. 2025, https://doi.org/10.3390/polym17060790
-
Paramonov, Valeriy M., et al. "In vitro targetability validation of peptide-functionalized mesoporous silica nanoparticles in the presence of serum proteins." Frontiers in Chemistry 8 (2020): 603616, https://doi.org/10.3389/fchem.2020.603616
-
Distributed under Open Access license CC BY 4.0, without modification.
Our services are For Research Use Only. We do not provide services to individuals.
